EUTM file information

018650609

CLOVER BIOPHARMACEUTICALS

February 7, 2022

Trademark Summary

The trademark application CLOVER BIOPHARMACEUTICALS was filed by Clover Biopharmaceuticals Ireland Limited, a corporation established under the laws of Ireland (the "Applicant"). The application was published for oppositions on March 6, 2022, and it was registered by office on June 13, 2022 without any oppositions.

It was designated 'Basic Application' for International Application 1661558 at the World Intellectual Property Organization (WIPO).

The application was filed in English (German was selected as the second language).

Change of name and professional address of the trademark registration was recorded on February 22, 2024.

Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceuticals, medical and veterinary preparations
    2. Sanitary preparations for medical purposes
    3. Dietetic food and substances adapted for medical or veterinary use, food for babies
    4. Dietary supplements for human beings and animals
    5. Plasters, materials for dressings
    6. Material for stopping teeth, dental wax
    7. Disinfectants
    8. Preparations for destroying vermin
    9. Fungicides, herbicides
    10. Pharmaceutical preparations for human use
    11. Antibiotics
    12. Vaccines
    13. Antibodies
    14. Anti-cancer preparations
    15. Antivirals
    16. Pharmaceutical preparations for treating respiratory diseases
    17. Oral vaccine preparations
    18. Vaccine preparations
    19. Influenza vaccine
    20. Human vaccine preparation
    21. Biochemical drug
    22. Biological tissue cultures for medical purposes
    23. Nutraceutical preparations for therapeutic or medical purposes
    24. Antiviral serum
    25. Depuratives
    26. Biological preparations for medical purposes
    27. Proteins for medical purposes, polypeptides for medical purposes
    28. Biochemicals for medical purposes.
  • The mark was filed in class 42 with following description of goods:
    1. Pharmaceutical drug development services
    2. Pharmaceutical research services
    3. Conducting early evaluations in the field of new pharmaceuticals
    4. Biological research
    5. Clinical trials
    6. Research and development services in the field of antibiotics
    7. Research and development services in the field of vaccines
    8. Research and development services in the field of antibodies
    9. Research and development services in the field of anti-cancer preparations
    10. Research and development services in the field of antivirals
    11. Research and development services in the field of respiratory diseases
    12. Biotechnology research.